Study to Assess the Efficacy and Safety of Favipiravir-HU

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The aim of the study is to assess the safety and efficacy of Favipiravir HU when administered to SARS-Cov- 2 patients in order to offer a safe and effective treatment to SARS-Cov-2 infection during the pandemic. The study is not for registration purposes and is not part of a series of studies for registration of Favipiravir HU.
Epistemonikos ID: 79acb041189adee9690684c3c1a463be3fdce2cf
First added on: Jun 29, 2021